CRLBF — Cresco Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual balance sheet for Cresco Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	136	224	119	103	138
Net Total Accounts Receivable
Net Total Receivables	32.4	44.7	56.9	52.5	52.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	249	422	326	278	294
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	301	457	508	486	456
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,233	1,780	1,584	1,358	1,355
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	253	288	281	200	94.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	759	1,025	957	853	881
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	473	756	627	506	475
Total Liabilities & Shareholders' Equity	1,233	1,780	1,584	1,358	1,355
Total Common Shares Outstanding